Quotes

Back To Menu

HDFC Pharma and Healthcare Fund - Regular (G) Equity - Pharma
INVEST

Plan: OPEN | Option: Growth | Nikhil Mathur

07 May 24 | 12:00 AM

12.49 -0.20 (-1.55%)

  • Underperforms

    0.00%

    Return (1Y)

    underperformed S&P BSE Healthcare TRI by -51.87%

  • Less Volatile

    0.67%

    Standard Deviation (1Y)

    Lower Equity - Pharma by -0.26%

  • Not so consistent

    4/8

    Months

    Has beaten Equity - Pharma

  • Value research rating

    Not Rated

Stock Composition

NAV

Critical Parameters

Everyone of us wants to create wealth by investing in top funds. Have a look at the key parameters that you need to check before deciding to invest in a mutual fund.

Returns

In last 1 year HDFC Pharma and Healthcare Fund - Regular (G), has beaten by -51.87% (CAGR difference)

0.00%

Underperforms

This is Alpha

Performance Chart for Rs

Invested in

08 May 2023

Risk

In last 1 year , the volatility of HDFC Pharma and Healthcare Fund - Regular (G) is Lower than by -0.26%

0.67%

Less Volatile

Risk Meter

Peer Comparison on Risk - Return

Consistency

For 4 out of Last 8 Months, i.e 50% of the times It beaten its benchmark, Equity - Pharma

Consistency Meter

Outperforming Stocks Vs. Underperforming Stocks

Based on the last 1year analysis, currently there are, the benchmark the benchmark

View Stock Composition